BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11552910)

  • 21. Meta-analysis of randomized and controlled treatment trials for achalasia.
    Wang L; Li YM; Li L
    Dig Dis Sci; 2009 Nov; 54(11):2303-11. PubMed ID: 19107596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of high-resolution endoscopic ultrasonography to assess esophageal wall damage after pneumatic dilation and botulinum toxin injection to treat achalasia.
    Schiano TD; Fisher RS; Parkman HP; Cohen S; Dabezies M; Miller LS
    Gastrointest Endosc; 1996 Aug; 44(2):151-7. PubMed ID: 8858320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of botulinum toxin injection for achalasia in Thai patients.
    Leelakusolvong S; Sinpeng T; Pongprasobchai S; Tanwandee T; Kachintorn U; Manatsathit S
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S67-72. PubMed ID: 17718248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin injections for achalasia symptoms can approximate the short term efficacy of a single pneumatic dilation: a survival analysis approach.
    Prakash C; Freedland KE; Chan MF; Clouse RE
    Am J Gastroenterol; 1999 Feb; 94(2):328-33. PubMed ID: 10022624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perendoscopic injection of botulinum toxin is effective in achalasia after failure of myotomy or pneumatic dilation.
    Annese V; Basciani M; Lombardi G; Caruso N; Perri F; Simone P; Andriulli A
    Gastrointest Endosc; 1996 Oct; 44(4):461-5. PubMed ID: 8905369
    [No Abstract]   [Full Text] [Related]  

  • 26. Complexities of managing achalasia at a tertiary referral center: use of pneumatic dilatation, Heller myotomy, and botulinum toxin injection.
    Vela MF; Richter JE; Wachsberger D; Connor J; Rice TW
    Am J Gastroenterol; 2004 Jun; 99(6):1029-36. PubMed ID: 15180721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of achalasia patients treated with botulinum toxin.
    D'Onofrio V; Miletto P; Leandro G; Iaquinto G
    Dig Liver Dis; 2002 Feb; 34(2):105-10. PubMed ID: 11926552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current trends in the management of achalasia.
    Bruley des Varannes S; Scarpignato C
    Dig Liver Dis; 2001 Apr; 33(3):266-77. PubMed ID: 11407673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of botulinum toxin as a diagnostic/therapeutic trial to help clarify an indication for definitive therapy in patients with achalasia.
    Katzka DA; Castell DO
    Am J Gastroenterol; 1999 Mar; 94(3):637-42. PubMed ID: 10086644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter.
    Fishman VM; Parkman HP; Schiano TD; Hills C; Dabezies MA; Cohen S; Fisher RS; Miller LS
    Am J Gastroenterol; 1996 Sep; 91(9):1724-30. PubMed ID: 8792688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of achalasia with botulinum toxin.
    López P; Castiella A; Montalvo I; Bujanda L; Alzate LF; Gil I; Arenas JI
    Rev Esp Enferm Dig; 1997 May; 89(5):367-74. PubMed ID: 9190142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term results of endoscopic injection of botulinum toxin in elderly achalasic patients with tortuous megaesophagus or epiphrenic diverticulum.
    Wehrmann T; Kokabpick H; Jacobi V; Seifert H; Lembcke B; Caspary WF
    Endoscopy; 1999 Jun; 31(5):352-8. PubMed ID: 10433043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome following pneumatic dilatation as initial therapy for idiopathic achalasia: an 18-year single-centre experience.
    Elliott TR; Wu PI; Fuentealba S; Szczesniak M; de Carle DJ; Cook IJ
    Aliment Pharmacol Ther; 2013 Jun; 37(12):1210-9. PubMed ID: 23659347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of botulinum toxin in the treatment of achalasia.
    Schiano TD; Parkman HP; Miller LS; Dabezies MA; Cohen S; Fisher RS
    Dig Dis; 1998; 16(1):14-22. PubMed ID: 9549033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Esophageal achalasia: intrasphincteric injection of botulinum toxin A versus balloon dilation.
    Muehldorfer SM; Schneider TH; Hochberger J; Martus P; Hahn EG; Ell C
    Endoscopy; 1999 Sep; 31(7):517-21. PubMed ID: 10533734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Achalasia treatment in the elderly: is botulinum toxin injection the best option?
    Zárate N; Mearin F; Baldovino F; Armengol JR; Malagelada JR
    Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):285-90. PubMed ID: 11953694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of previous treatment on results of laparoscopic Heller myotomy for achalasia.
    Patti MG; Feo CV; Arcerito M; De Pinto M; Tamburini A; Diener U; Gantert W; Way LW
    Dig Dis Sci; 1999 Nov; 44(11):2270-6. PubMed ID: 10573373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pneumatic dilatation and surgical myotomy for achalasia.
    Lopushinsky SR; Urbach DR
    JAMA; 2006 Nov; 296(18):2227-33. PubMed ID: 17090769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical study on combined therapy of botulinum toxin injection and small balloon dilation in patients with esophageal achalasia.
    Zhu Q; Liu J; Yang C
    Dig Surg; 2009 Feb; 26(6):493-8. PubMed ID: 20090338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current therapies for achalasia: comparison and efficacy.
    Vaezi MF; Richter JE
    J Clin Gastroenterol; 1998 Jul; 27(1):21-35. PubMed ID: 9706766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.